Get the Stockscreener App
3.15
3.08%
-0.10
After Hours:
3.00
-0.15
-4.76%
22nd Century Group, Inc. stock is traded at $3.15, with a volume of 77,255.
It is down -3.08% in the last 24 hours and down -45.03% over the past month.
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
See More
Previous Close:
$3.25
Open:
$3.2
24h Volume:
77,255
Relative Volume:
0.09
Market Cap:
$5.41M
Revenue:
$29.78M
Net Income/Loss:
$-39.94M
P/E Ratio:
-0.0509
EPS:
-61.9139
Net Cash Flow:
$-16.12M
1W Performance:
-1.25%
1M Performance:
-45.03%
6M Performance:
-95.76%
1Y Performance:
-99.07%
1-Day Range:
$3.07
$3.29
1-Week Range:
$3.07
$3.4735
52-Week Range:
$3.01
$581.85
22nd Century Group, Inc. Stock (XXII) Company Profile
Name
22nd Century Group, Inc.
Sector
Industry
Phone
716-270-1523
Address
8560 Main Street, Williamsville, NY
Compare XXII with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
3.15 | 5.41M | 29.78M | -39.94M | -16.12M | -61.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-22 | Initiated | Alliance Global Partners | Buy |
| Jun-15-22 | Initiated | Craig Hallum | Buy |
| Mar-08-22 | Initiated | ROTH Capital | Buy |
| Jul-23-21 | Initiated | Cowen | Outperform |
| Oct-16-17 | Reiterated | Chardan Capital Markets | Buy |
| Aug-11-16 | Reiterated | Chardan Capital Markets | Buy |
View All
22nd Century Group, Inc. Stock (XXII) Latest News
12 Cannabis Stocks to Buy Now in 2025 - MarketBeat
Emerging Growth Research Releases New Initiation Report on the 22nd Century Group (XXII) - Newsfile
22nd Century : FDA Lead Scientist Discusses 22nd Century’s SPECTRUM® Research Cigarettes in Public Webcast - Marketscreener.com
XXII stock plunges to 52-week low, touches $3.03 amid market rout - Investing.com Canada
XXII stock plunges to 52-week low, touches $3.03 amid market rout By Investing.com - Investing.com South Africa
22nd Century to Present at the Emerging Growth Conference on February 19, 2025 - Marketscreener.com
Exclusive: 22nd Century Group Unveils Strategic Vision at Emerging Growth ConferenceCEO Takes Center Stage - StockTitan
Weiss Ratings Reiterates Sell (E) Rating for 22nd Century Group (NASDAQ:XXII) - Defense World
22nd Century files to sell 104,124 shares of common stock for holders - MSN
22nd Century Sells Cannabis Operations - Tobacco Reporter
Investors Buy 22nd Shares ‘Above Market’ - Tobacco Reporter
22nd Century Launches Public Offering - Tobacco Reporter
22nd Century Submits CBD Drug Master File - Tobacco Reporter
22nd Century Eliminates $2.3 million of Debt - Tobacco Reporter
22nd Century Group (NASDAQ: XXII) and Smoker Friendly Forge New Agreement – Market - HPBL
22nd Century Group, Inc. (NASDAQ:XXII) Short Interest Update - Defense World
22nd Century Group (NASDAQ:XXII) Regains Compliance with Nasdaq Listing Rule 5550(a)(2) - Defense World
22nd Century Regains Full Compliance with Nasdaq Continued Listing Standards - The Manila Times
22nd Century Group Regains Nasdaq Compliance, Secures Exchange Listing - StockTitan
22nd Century Group Announces Strategic Agreement with Smoker Friendly – Market - HPBL
FDA Publishes Proposed New Tobacco Product Standard for Nicotine Yield, Citing VLN from 22nd Century as the Only Combustible Cigarette That Complies with the New Standard - The Manila Times
22nd Century Group's VLN Cigarettes Already Meet FDA's Proposed Nicotine Reduction Standard - StockTitan
22nd Century Group Resets Conversion Price in Senior Secured Credit Facility - Defense World
Washington Post Story Featuring 22nd Century VLN Products Highlights Proposed FDA Reduced Nicotine Content Policy Could Initially Benefit An Estimated 13 Million Smokers - The Manila Times
22nd Century's VLN Cigarettes Take Spotlight as FDA's Nicotine Reduction Plan Advances - StockTitan
22nd Century Group Stock Rises On Proposed FDA Mandate On Nicotine Content: Retail's Extremely Bullish - MSN
22nd Century Group resets debt conversion price By Investing.com - Investing.com Canada
22nd Century Group resets debt conversion price - Investing.com
XXII22nd Century Group Inc. Latest Stock News & Market Updates - StockTitan
22nd Century ready to support FDA's reduced nicotine cigarette policy, stock up 30% - Seeking Alpha
22nd Century Stands Ready to Support the Adoption of FDA Proposed Tobacco Product Standard to Mandate Reduced Nicotine Content in Cigarettes with its VLN Cigarettes - The Manila Times
22nd Century Group Ready to Lead FDA's Reduced Nicotine Cigarette Revolution with VLN Brand - StockTitan
22nd Century Group (NASDAQ:XXII) Stock Quotes, Forecast and News Summary - Benzinga
Nasdaq Down Over 2%; Walgreens Posts Upbeat Results - Benzinga
Dow Dips 500 Points; US Economy Adds 256,000 Jobs In December - Benzinga
22nd Century & Smoker Friendly Expand Partnership - Tobacco Reporter
22nd Century Expands Market Reach with New Agreement - TipRanks
22nd Century Group, Inc. Signs New, Expanded License and Manufacturing Agreement with Smoker Friendly International, LLC - Marketscreener.com
22nd Century Group signs expanded license and manufacturing agreement with Smoker Friendly - MSN
22nd Century Group Signs New, Expanded License and Manufacturing Agreement with Smoker Friendly - The Manila Times
22nd Century Group Expands Smoker Friendly Partnership with Premium Brand Launch, 5-Year Deal - StockTitan
StockNews.com Begins Coverage on 22nd Century Group (NASDAQ:XXII) - MarketBeat
22nd Century Group announces reverse stock split By Investing.com - Investing.com Nigeria
22nd Century Group, Inc. Stock (XXII) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):